Apex Healthcare Berhad Past Earnings Performance
Past criteria checks 1/6
Apex Healthcare Berhad has been growing earnings at an average annual rate of 39.7%, while the Pharmaceuticals industry saw earnings growing at 11.6% annually. Revenues have been growing at an average rate of 8.2% per year. Apex Healthcare Berhad's return on equity is 10.4%, and it has net margins of 8.6%.
Key information
39.7%
Earnings growth rate
39.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 7.7% |
| Revenue growth rate | 8.2% |
| Return on equity | 10.4% |
| Net Margin | 8.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
We Think That There Are More Issues For Apex Healthcare Berhad (KLSE:AHEALTH) Than Just Sluggish Earnings
Dec 04
Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation
May 08Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025
Aug 28Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09
Apr 19Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09
Feb 25Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year
Aug 24Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly
May 11Is Apex Healthcare Berhad (KLSE:AHEALTH) A Smart Pick For Income Investors?
Apr 08Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)
Mar 11Does Apex Healthcare Berhad (KLSE:AHEALTH) Deserve A Spot On Your Watchlist?
Feb 26Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?
Feb 11
These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well
Jan 25Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio
Jan 07Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?
Dec 20Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment
Dec 05Revenue & Expenses Breakdown
How Apex Healthcare Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 964 | 83 | 127 | 0 |
| 30 Jun 24 | 962 | 89 | 128 | 0 |
| 31 Mar 24 | 939 | 395 | 126 | 0 |
| 31 Dec 23 | 936 | 398 | 124 | 0 |
| 30 Sep 23 | 917 | 413 | 122 | 0 |
| 30 Jun 23 | 913 | 415 | 118 | 0 |
| 31 Mar 23 | 908 | 109 | 116 | 0 |
| 31 Dec 22 | 878 | 101 | 112 | 0 |
| 30 Sep 22 | 855 | 87 | 108 | 0 |
| 30 Jun 22 | 834 | 74 | 107 | 0 |
| 31 Mar 22 | 807 | 63 | 102 | 0 |
| 31 Dec 21 | 771 | 59 | 98 | 0 |
| 30 Sep 21 | 735 | 53 | 94 | 0 |
| 30 Jun 21 | 693 | 53 | 87 | 0 |
| 31 Mar 21 | 685 | 54 | 90 | 0 |
| 31 Dec 20 | 699 | 56 | 93 | 0 |
| 30 Sep 20 | 708 | 56 | 97 | 0 |
| 30 Jun 20 | 719 | 56 | 101 | 0 |
| 31 Mar 20 | 704 | 56 | 100 | 0 |
| 31 Dec 19 | 689 | 53 | 99 | 0 |
| 30 Sep 19 | 681 | 56 | 98 | 0 |
| 30 Jun 19 | 666 | 56 | 97 | 0 |
| 31 Mar 19 | 662 | 57 | 97 | 0 |
| 31 Dec 18 | 653 | 59 | 97 | 0 |
| 30 Sep 18 | 642 | 55 | 96 | 0 |
| 30 Jun 18 | 635 | 51 | 95 | 0 |
| 31 Mar 18 | 634 | 48 | 94 | 0 |
| 31 Dec 17 | 620 | 44 | 90 | 0 |
| 30 Sep 17 | 612 | 38 | 89 | 0 |
| 30 Jun 17 | 597 | 36 | 87 | 0 |
| 31 Mar 17 | 588 | 35 | 86 | 0 |
| 31 Dec 16 | 581 | 35 | 85 | 0 |
| 30 Sep 16 | 571 | 42 | 84 | 0 |
| 30 Jun 16 | 557 | 39 | 82 | 0 |
| 31 Mar 16 | 534 | 36 | 79 | 0 |
| 31 Dec 15 | 527 | 34 | 79 | 0 |
| 30 Sep 15 | 516 | 30 | 78 | 0 |
| 30 Jun 15 | 510 | 32 | 77 | 0 |
| 31 Mar 15 | 508 | 33 | 76 | 0 |
| 31 Dec 14 | 499 | 34 | 75 | 0 |
| 30 Sep 14 | 482 | 32 | 74 | 0 |
| 30 Jun 14 | 461 | 31 | 71 | 0 |
| 31 Mar 14 | 443 | 30 | 69 | 0 |
| 31 Dec 13 | 418 | 30 | 66 | 0 |
Quality Earnings: AHEALTH has a high level of non-cash earnings.
Growing Profit Margin: AHEALTH's current net profit margins (8.6%) are lower than last year (45%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AHEALTH's earnings have grown significantly by 39.7% per year over the past 5 years.
Accelerating Growth: AHEALTH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AHEALTH had negative earnings growth (-79.9%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-16.4%).
Return on Equity
High ROE: AHEALTH's Return on Equity (10.4%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 23:48 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Apex Healthcare Berhad is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ken-Wern Lim | Affin Hwang Investment Bank |
| Khir Goh | AmInvestment Bank Berhad |
| null null | BIMB Securities Sdn. Bhd |